These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 668868)

  • 21. Poly (2-vinylpyridine 1-oxide) in silicosis therapy: effective molecular weight.
    Hasirci VN; Holt PF
    Int Arch Occup Environ Health; 1977; 38(3):177-88. PubMed ID: 832913
    [No Abstract]   [Full Text] [Related]  

  • 22. [Results of a clinical trial of polyvinoxide in silicosis].
    Glotova KV; Senkevich NA; Kaliteevskaia TN; Pichugin VA; Manzhosova GB
    Gig Tr Prof Zabol; 1981 Aug; (8):14-7. PubMed ID: 7026373
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antisilicotic properties of polyvinylpyridine-N-oxide with a different molecular weight].
    Dubovik BV; Shadurskiĭ KS; Etlis VS; Lushnikova GA; Shevchuk AS
    Farmakol Toksikol; 1971; 34(3):352-7. PubMed ID: 5568700
    [No Abstract]   [Full Text] [Related]  

  • 24. The effects of tetrandrine (TT) and polyvinylpyridine-N-oxide (PVNO) on gene expression of type I and type III collagens during experimental silicosis.
    Liu BC; He YX; Miao Q; Wang HH; You BR
    Biomed Environ Sci; 1994 Sep; 7(3):199-204. PubMed ID: 7848548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of polyvinylpyridine N-oxide on the elimination from the lungs of radioactive cobalt particles which have entered separately and together with quartz dust].
    Shpringer OA; Pavlov BD; Shadurskiĭ KS; Dubovik VV; Dergachev VI
    Farmakol Toksikol; 1974; 37(6):729-33. PubMed ID: 4377132
    [No Abstract]   [Full Text] [Related]  

  • 26. [Generative function in experimental exposure to polyvinylpyridine N-oxide].
    Bolonova LN; Iulish NR
    Farmakol Toksikol; 1981; 44(4):470-3. PubMed ID: 7286209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mode of action of poly(vinylpyridine-N-oxide) in preventing silicosis: effective scavenging of carbonate anion radical.
    Goldstein S; Czapski G; Heller A
    Chem Res Toxicol; 2006 Jan; 19(1):86-91. PubMed ID: 16411660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Application and analysis of biochemical indices for the evaluation of antisilicosis treatment. Study on anti-silicosis therapy and its evaluation research group].
    Liu B; Qin X
    Wei Sheng Yan Jiu; 1998 Jul; 27(4):222-4. PubMed ID: 10682587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antisilicosis activity of PVPO administered intratracheally and by inhalation (an experimental study)].
    Rodkina BS; Bolonova LN
    Gig Tr Prof Zabol; 1979 Sep; (9):32-6. PubMed ID: 535751
    [No Abstract]   [Full Text] [Related]  

  • 30. [Trials of casual treatment of silicosis].
    Idec-Sadkowska I; Andrzejak R; Antonowicz-Juchniewicz J; Kaczmarek-Wdowiak B
    Med Pr; 2006; 57(3):271-80. PubMed ID: 17125034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of experimental silicosis with polyvinyl-pyridine-N-oxide].
    Bogdanskaia NI
    Gig Tr Prof Zabol; 1973 May; 17(5):22-5. PubMed ID: 4771393
    [No Abstract]   [Full Text] [Related]  

  • 32. [Influence of polyvinylpyridine-N-oxide on matured experimental silicosis in the liver-spleen test].
    Heeren E; Eger W; Einbrodt HJ
    Beitr Silikoseforsch Pneumokoniose; 1971; 23(3):137-50. PubMed ID: 5171409
    [No Abstract]   [Full Text] [Related]  

  • 33. [Regression of experimental silicotic granuloma under the influence of polyvinylpyridin-N-oxide].
    Grundmann E; Schlipköter HW
    Verh Dtsch Ges Pathol; 1969; 53():367-70. PubMed ID: 4191095
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term follow-up observations of the therapeutic effect of PVNO on human silicosis.
    Zhao JD; Liu JD; Li GZ
    Zentralbl Bakteriol Mikrobiol Hyg B; 1983 Oct; 178(3):259-62. PubMed ID: 6659745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Decomposition of collagen in experimental silicosis following treatment with polyvinylpyridine-N-oxide in dependence on the dosage].
    Pott F; Dehnen W; Brockhaus A
    Beitr Klin Erforsch Tuberk Lungenkr; 1970; 140(3):259-67. PubMed ID: 4314381
    [No Abstract]   [Full Text] [Related]  

  • 36. [Determination of serum polyvinylpyridine-N-oxide after intravenous administration in silicosis patients].
    Grünspan M; Antweiler H; Marcic I
    Beitr Silikoseforsch Pneumokoniose; 1971; 23(3):101-13. PubMed ID: 5171408
    [No Abstract]   [Full Text] [Related]  

  • 37. [Stabilizing action of glutamic acid on the membrane structures of the coniophage].
    Shnaĭdman IM; Martirosova ZhE
    Gig Tr Prof Zabol; 1985 Mar; (3):55-7. PubMed ID: 2861146
    [No Abstract]   [Full Text] [Related]  

  • 38. [Method of determination of polyvinylpyridine N-oxide in the urine and feces].
    Bolonova LN; Rodkina BS
    Lab Delo; 1977; (12):744-5. PubMed ID: 75327
    [No Abstract]   [Full Text] [Related]  

  • 39. [Inhalation treatment of silicosis with Kexiping].
    Gurilkov T; Stoevska M
    Probl Khig; 1989; 14():161-6. PubMed ID: 2635309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Relationship of the chemical structure and antisilicotic properties of a series of tetrasubstituted amino esters of polymethacrylic acid (the possibility of the directed synthesis of antisilicotic polymers)].
    Aronova GV; Borodulina SN; Katsnel'son BA; Postovskiĭ IIa
    Gig Tr Prof Zabol; 1980 May; (5):23-5. PubMed ID: 7380309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.